{"nct_id":"NCT04657822","title":"Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2021-06-10","start_date_type":"ACTUAL","primary_completion_date":"2031-06-10","primary_completion_date_type":"ESTIMATED","completion_date":"2031-06-10","completion_date_type":"ESTIMATED","phases":["PHASE4"],"tickers":["NVS"]}